Library · Skin & hair · Skin regeneration and collagen synthesis enhancement
SCO-094
SCO-094, Collagen Mimetic Peptide-094, Synthetic Collagen Fragment-094
An early-2010s synthetic peptide studied for dermatology, aimed at boosting collagen synthesis and skin regeneration. Preliminary lab work suggests effects on fibroblast activity and Type I/III collagen, but it remains in early research with no approved use.
Research score 75/100. Reference only, not a dose.
- Skin Health
- Collagen Production
- Wound Healing
- Anti-aging
- US status
- Research Chemical
- Approval
- Research Chemical Only
- Evidence
- Investigational dual GLP-1 and GIP receptor agonist. Developed for Type 2 Diabetes, Obesity, and NASH. Shows potential for significant weight loss.
- Research score
- 75 / 100
- Indication
- Research Only - No Medical Indication
- Origin
- USA
- Source category
- Skin & Dermatology
- Status group
- Research chemical
Mechanism
Binds dermal fibroblast receptors to trigger TGF-β/SMAD signaling, raising collagen, elastin, and glycosaminoglycan output while inhibiting matrix-degrading enzymes; also promotes keratinocyte renewal via EGFR pathway activation.
Safety file
Early trials describe it as well tolerated, with GI-type effects reported; no severe drug-related signals reported so far.
- Mild skin irritation
- Temporary redness
- Contact dermatitis in sensitive individuals